Dear friends , For this years annual meeting in beautiful Vancouver, BC June 2 - 5 2026 we are happy to partner with the Canadian Society for Pharmaceutical Sciences CSPS and the Canadian Chapter of the Controlled Release Society cc-CRS ...
Call for Abstracts for CBS/CSPS/cc-CRS Conference is now open!
0 comments
by
Call for Abstracts is OPEN The Canadian Biomaterials Society CBS , the Canadian Society for Pharmaceutical Sciences CSPS , and the Controlled Release Society cc-CRS are joining forces to host a landmark joint conference at UBC Vancouver...
Save the Date for CBS2026! June 2–5, 2026
0 comments
by
Overview The Canadian Biomaterials Society CBS , the Canadian Society for Pharmaceutical Sciences CSPS , and the Controlled Release Society cc-CRS are joining forces to host a landmark joint conference at UBC Vancouver...
Random and Aligned Electroapun PET Nanofibers: the Roles of Topography and Bioactive Coatings for Complete, Stable Endothelialization of Vascular Grafts
comments
There have been considerable efforts to develop prosthetic small-diameter below 6mm vascular grafts VGs as an alternative to autologous grafts to bypass or replace occluded blood vessels...
Examining The Proinflammatory and Profibrotic Effects of Adsorbed Damage-Associated-Molecular-Patterns and Toll-Like Receptor 2-Dependent Signaling in Macrophages
comments
The foreign body reaction is an aberrant wound healing process that occurs in response to an implanted biomaterial, which can lead to it failing prematurely...
Liposomes, since their discovery by Bangham et al. in 1965, have been utilized for a wide variety of applications ranging from drug delivery vehicles to cosmeceuticals and food nanotechnology...
In recent years, the development of multiplexing assays collecting multiple endpoints from one single sample has increased in a number of fields including toxicology and drug development ...
Atherosclerotic vascular disease, including peripheral arterial disease PAD , is the leading cause of mortality in North America, with PAD accounting for 1 5 of all vascular disease 1 ...